Predicting aggressive cancer – Dr. Chu Chen and colleagues are pinpointing the genetic changes associated with oral cancer risk and progression. Identifying these genetic patterns could help predict the aggressiveness of a patient’s cancer and ultimately help doctors decide whether surgery, which can cause facial disfiguring and psychological stress, is appropriate. Our investigators are also assessing whether these genes would be useful for predicting recurrence, metastasis and survival in oral cancer patients. Learn more »
Preventing unnecessary surgery – Dr. Chen and colleagues have, for the first time, identified a four-gene set that signals when oral cancer has spread to lymph nodes in the neck. Published in 2011, the discovery could lead to a test that would help doctors identify which patients require surgery to remove their lymph nodes and those who would not benefit from such an aggressive treatment regimen. Learn more »
Restricting tumor growth – Drs. Chen and Eduardo Mendez have identified gene signatures in patient tumors that can better predict patient survival. Dr. Mendez is also researching novel methods of blocking the same set of genes as a way to impact the growth of cancer cells, a research emphasis that is in the pre-clinical phase.
Advancing treatment – Dr. Renato Martins is testing new combinations of drug therapies to improve treatment of head and neck cancers.